Business Daily Media

Men's Weekly

.

Haoma Medica to Present Scientific Data on NaQuinate, a Potential New Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

  • Written by PR Newswire
Haoma Medica to Present Scientific Data on NaQuinate, a Potential New Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

LONDON, Sept. 10, 2020 /PRNewswire/ -- Haoma Medica announced today that it will present three scientific posters on NaQuinate at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting, which this year takes place as a virtual event from the 11-15 September. NaQuinate, a naphthoquinone carboxylic acid, is being developed as a novel orally administered therapeutic for osteoporosis. ''Haoma Medica is dedicated to investigating new ways to treat osteoporosis and maintain healthy aging and we look forward to sharing new pre-clinical data for NaQuinate at this key meeting with bone health experts'' said Prof Stephen Hodges, Haoma Medica's Chief Scientific Officer.

Haoma Medica will present the following abstracts at ASBMR:

  • NaQuinate: A Drug that Selectively Synergizes with Mechanical Loading Stimuli In Vivo to Generate Greater Cortical Bone Mass and Architectural ModificationsPlenary Poster Presentation Number: P-300
  • NaQuinate Protects Against Ovariectomy-Induced Changes in Cortical Bone Mass and Architecture Through a Regionally Targeted MechanismPoster Presentation Number: P-734
  • NaQuinate, a Vitamin K Catabolite, is Found in Blood After Oral Vitamin K Administration and it can Reduce Osteoclast Activity Without Effecting Osteoclast Number in CulturePoster Presentation Number: P-339

About OsteoporosisOsteoporosis is a silent disease often not presenting with any signs or symptoms until a fracture occurs. It thus remains an underdiagnosed and undertreated disease.

Osteoporosis results in bone loss and changes in bone quality that occurs through the normal aging process leading to fragile bones. Fragile bones lead to fractures, which progresses into a downward spiral of disability, loss of independence and increased mortality with considerable social and economic burden. Fragility fractures are therefore a major obstacle to healthy aging. Worldwide there is a fragility fracture every 3 seconds.

According to the National Osteoporosis Foundation about 54 million Americans have osteoporosis with studies suggesting one in two women and one in four men aged 50 and older will have a fragility fracture (from low level impact often occurring from a minor bump/fall from standing height) within their lifespan.

About Haoma MedicaHaoma Medica Ltd is a clinical-stage biotechnology company focused on the development of therapeutics to maintain bone and vascular health.

For more information, please visit www.haomamedica.com[1]

Logo - https://mma.prnasia.com/media2/1251548/Haoma_Medica_Logo.jpg?p=medium600[2]

Investor Relations ContactName: Carmen Greco                                                e-mail: carmen.greco@haomamedica.com[3]          Phone: +44 (0)207 629 1954                                         

Source: Haoma Medica Ltd.

References

  1. ^ www.haomamedica.com (nam03.safelinks.protection.outlook.com)
  2. ^ https://mma.prnasia.com/media2/1251548/Haoma_Medica_Logo.jpg?p=medium600 (mma.prnasia.com)
  3. ^ carmen.greco@haomamedica.com (www.prnasia.com)

Read more https://www.prnasia.com/story/archive/3120246_AE20246_0

Landowners Offered $30,000 Per Year for Just 1 Hectare: The Rise of 5MW Battery Projects Across Australia

In a pivotal shift reshaping Australia’s renewable energy landscape, landowners in Queensland, New South Wales, and Victoria are being offered up ...

Major national security tech alliance launches with Aerologix a founding member

Australia’s leading drone intelligence pioneer bolsters sovereign tech power Australia’s leading aerial data and drone intelligence platform, Aer...

Chris Hancock AM Honoured as 2025 Communications Ambassador

SYDNEY Chris Hancock AM, former CEO of AARNet, has been awarded the prestigious Communications Ambassador title at the 2025 Telecommunications Indus...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

Sell by LayBy